RBL Communications
  • Home
  • About
  • Services
  • Investment Hub
  • Contact
Select Page

Boba Mint Celebrates Milestones with Tanjea: A Blockchain Mobile Game

May 16, 2024

Vancouver, British Columbia – May 16, 2024 – Boba Mint Holdings Ltd. (CSE: TNJ) (“Boba Mint” or the “Company”), Boba Mint, the innovative gaming company behind the popular blockchain mobile game Tanjea, is thrilled to announce...

Boba Mint Holdings Ltd. Preparing to Launch a New Update to Its Play-To-Earn NFT Game, Tanjea, in May

May 9, 2024

Vancouver, British Columbia – May 9, 2024 – Boba Mint Holdings Ltd. (CSE: TNJ) (“Boba” or the “Company”), a leading innovator in blockchain mobile gaming, is pleased to announce the upcoming launch of a captivating new update to its...

Anfield Energy Submits Plan of Operation to the State of Utah for the Velvet-Wood Mine as the Company Continues its March Towards Uranium Production

May 1, 2024

VANCOUVER, British Columbia, May 01, 2024 – Anfield Energy, Inc. (TSX.V: AEC; OTCQB: ANLDF; FRANKFURT: 0AD) (“Anfield” or “the Company”) is pleased to announce that it has submitted its Plan of Operation for its Velvet-Wood mine to the State of Utah and BLM....

Boba Mint Holdings Ltd. Approved for CSE Listing on April 26, 2024

Apr 26, 2024

Vancouver, British Columbia – April 25, 2024 – Boba Mint Holdings Ltd. (CSE: TNJ) (“Boba” or the “Company”) is pleased to announce that it has received final confirmation from the Canadian Securities Exchange (the “CSE”)...

Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID

Apr 23, 2024

TORONTO, April 23, 2024 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases, medical...

Revive Therapeutics Announces FDA Acceptance of Meeting Request for Long COVID Diagnostic Product

Apr 18, 2024

TORONTO, April 18, 2024 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases, medical...
« Older Entries
Next Entries »

Follow Us

Categories

  • Al O'Grady
  • Anfield Energy
  • Blog
  • Boba Mint Holdings
  • Kontrol Energy
  • News
  • PharmaDrug
  • Revive
  • Uncategorized
  • Home
  • About
  • Services
  • Investment Hub
  • Contact
  • Facebook
  • X
© COPYRIGHT 2025. RBL Communications Inc. ALL RIGHTS RESERVED.